Millions of SEK in funding for malaria research at Umeå University

The molecular biologist Cathrine Persson at Umeå University has been allotted SEK 2.5 million from the U.S. National Institutes of Health (NIH) for research on a vaccine against malaria.

The project “Immunogenicity of synthetic peptide malaria vaccines” spans five years and is designed to study the protection offered by various synthetic vaccines against malaria. Cathrine Persson is collaborating with Professor Elizabeth Nardin, NYU School of Medicine in New York.

The funding is being provided by the National Institute of Allergy and Infectious Diseases (NIAID), one of the 27 institutes and centers that make up the NIH, a federal body that both pursues and provides support for various types of medical research in the U.S. and abroad. The competition for this funding is extremely stiff, and it is not often that scientists in Sweden are selected for grants. The application submitted by Cathrine and her associate was given high scores in the assessment process. Malaria is a major world health problem, and there is no vaccine at present.

“It’s our hope that we will be able to come up with an effective vaccine. This would be a tremendous breakthrough in efforts to develop protection against malaria,” says Cathrine Persson.

Malaria claims several millions of human lives every year and is caused by a group of single-cell parasites (so-called protzoas) that are transmitted to humans by mosquitoes. People who live in malaria-infested areas develop antibodies against the Circumsporozoite protein (CS), a protein on the surface of the malaria parasite. Owing to the ability of CS to stimulate our immune defense, it is included in several trial vaccines that have been tested on humans. A major problem with all vaccine trials is that there is no good way to measure to what extent an individual has developed protection against malaria after being vaccinated. By constructing hybrid parasites that contain parts of the CS protein, Cathrine Persson’s research aims to show what parts of CS are best at stimulating our immune defense. The hybrid parasites will moreover be used as a tool to analyze the outcome of vaccination trials.

Media Contact

Hans Fällman alfa

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors